Michael A. Fischbach, Ph.D.
Associate Professor, Department of Bioengineering,Department of Microbiology & Immunology, Stanford UniversityMichael A. Fischbach’s website
Fischbach is an associate professor in Stanford University’s Bioengineering Department and the Microbiology & Immunology Department. Additionally, he is an institute scholar at Stanford ChEM-H and director of the Stanford Microbiome Therapies Initiative. Fischbach is also a co-founder and director of Federation Bio and Viralogic, a co-founder of Revolution Medicines, a member of the scientific advisory board of NGM Biopharmaceuticals, and an innovation partner at The Column Group.